Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2024.08.021
PubMed Identifier: 39242323
Publication URI: http://europepmc.org/abstract/MED/39242323
Type: Journal Article/Review
Volume: 86
Parent Publication: European urology
Issue: 6
ISSN: 0302-2838